Inhibition of phosphatidylinositol 3-kinase/AKT pathway induces apoptosis in diffuse large B-cell lymphoma

被引:0
|
作者
Uddin, Shahab [1 ]
Hussain, Azhar R. [1 ]
Siraj, Abdul K. [1 ]
Bavi, Prashant [1 ]
Al-Kuraya, Khawla S. [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2191
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Role of phosphatidylinositol 3-kinase/AKT pathway in diffuse large B-cell lymphoma survival
    Uddin, S
    Hussain, AR
    Bavi, P
    Siraj, AK
    Al-Kuraya, KS
    [J]. BLOOD, 2005, 106 (11) : 282B - 282B
  • [2] Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival
    Uddin, Shahab
    Hussain, Azhar R.
    Siraj, Abdul K.
    Manogaran, Pulicat S.
    Al-Jomah, Naif A.
    Moorji, Azadali
    Atizado, Valerie
    Al-Dayel, Fouad
    Belgaumi, Asim
    El-Solh, Hassan
    Ezzat, Adnan
    Bavi, Prashant
    Al-Kuraya, Khawla S.
    [J]. BLOOD, 2006, 108 (13) : 4178 - 4186
  • [3] Involvement of phosphatidylinositol 3-kinase/Akt pathway in inhibition of apoptosis in B-CLL cells.
    Shehata, MM
    Schwarzmeier, JD
    Hilgarth, M
    Hoelbl, A
    Lehner, C
    Hubmann, R
    Duechler, M
    Jaeger, U
    [J]. BLOOD, 2003, 102 (11) : 431A - 431A
  • [5] Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis
    Wang, Yan
    Jiang, Xiao-Yu
    Liu, Li
    Jiang, Hui-Qing
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (33) : 5186 - 5191
  • [6] Inhibition of Phosphatidylinositol 3-Kinase Is Effective to Suppress the Growth of CD20-Negative Refractory Diffuse Large B-Cell Lymphoma Cells
    Nakamaki, Tsuyoshi
    Fukuchi, Kunihiko
    Nakashima, Hidetoshi
    Ariizumi, Hirotsugu
    Maeda, Takashi
    Saito, Bungo
    Yanagisawa, Kouji
    Tomoyasu, Shigeru
    Shiozawa, Eisuke
    Yamochi-Onizuka, Toshiko
    Ota, Hidekazu
    [J]. BLOOD, 2011, 118 (21) : 1040 - 1041
  • [7] Inhibition of focal adhesion kinase induces apoptosis in bladder cancer cells via Src and the phosphatidylinositol 3-kinase/Akt pathway
    Kong, Debo
    Chen, Feng
    Sima, Ni
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (05) : 1725 - 1731
  • [8] Is there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapy
    Luttwak, Efrat
    Smith, Mitchell R.
    Zelenetz, Andrew D.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (12) : 1331 - 1334
  • [9] Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling
    Wang, Jingjing
    Zhang, Yang
    Liu, Xianling
    Ma, Jinan
    Liu, Ping
    Hu, Chunhong
    Zhang, Guangsen
    [J]. ONCOLOGY REPORTS, 2014, 32 (06) : 2557 - 2563
  • [10] Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma
    Lenz, Georg
    Hawkes, Eliza
    Verhoef, Gregor
    Haioun, Corinne
    Thye Lim, Soon
    Seog Heo, Dae
    Ardeshna, Kirit
    Chong, Geoffrey
    Haaber, Jacob
    Shi, Wei
    Gorbatchevsky, Igor
    Lippert, Susanne
    Hiemeyer, Florian
    Piraino, Paolo
    Beckmann, Georg
    Pena, Carol
    Buvaylo, Viktoriya
    Childs, Barrett H.
    Salles, Gilles
    [J]. LEUKEMIA, 2020, 34 (08) : 2184 - 2197